Annual SGA
$64.35 M
+$9.80 M+17.96%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual SGA is $64.35 million, with the most recent change of +$9.80 million (+17.96%) on December 31, 2023.
- During the last 3 years, ZNTL annual SGA has risen by +$30.46 million (+89.90%).
- ZNTL annual SGA is now at all-time high.
Performance
ZNTL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$14.61 M
-$2.15 M-12.85%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly SGA is $14.61 million, with the most recent change of -$2.15 million (-12.85%) on September 30, 2024.
- Over the past year, ZNTL quarterly SGA has dropped by -$1.34 million (-8.43%).
- ZNTL quarterly SGA is now -25.61% below its all-time high of $19.64 million, reached on June 30, 2022.
Performance
ZNTL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.74 B
-$179.28 M-5.03%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM SGA is -$3.74 billion, with the most recent change of -$179.28 million (-5.03%) on September 30, 2024.
- Over the past year, ZNTL TTM SGA has dropped by -$3.80 billion (-6426.93%).
- ZNTL TTM SGA is now -4407.29% below its all-time high of -$82.99 million.
Performance
ZNTL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ZNTL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.0% | -8.4% | -6426.9% |
| 3 y3 years | +89.9% | -8.4% | -6426.9% |
| 5 y5 years | +1219.8% | -8.4% | -6426.9% |
ZNTL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.2% | -25.6% | +49.8% | -205.3% | at low |
| 5 y | 5-year | at high | +660.7% | -25.6% | +381.2% | -4407.3% | at low |
| alltime | all time | at high | +1219.8% | -25.6% | +794.5% | -4407.3% | at low |
Zentalis Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.61 M(-12.9%) | $63.48 M(-2.1%) |
| Jun 2024 | - | $16.76 M(+6.5%) | $64.82 M(+1.7%) |
| Mar 2024 | - | $15.74 M(-3.8%) | $63.72 M(-1.0%) |
| Dec 2023 | $64.35 M(+18.0%) | $16.36 M(+2.6%) | $64.35 M(+8.8%) |
| Sep 2023 | - | $15.95 M(+1.8%) | $59.12 M(+7.1%) |
| Jun 2023 | - | $15.66 M(-4.3%) | $55.18 M(-6.7%) |
| Mar 2023 | - | $16.37 M(+47.0%) | $59.16 M(+8.4%) |
| Dec 2022 | $54.55 M(+33.2%) | $11.14 M(-7.3%) | $54.55 M(+2.6%) |
| Sep 2022 | - | $12.01 M(-38.8%) | $53.17 M(+6.3%) |
| Jun 2022 | - | $19.64 M(+66.9%) | $50.03 M(+22.8%) |
| Mar 2022 | - | $11.77 M(+20.6%) | $40.76 M(-0.5%) |
| Dec 2021 | $40.94 M | $9.75 M(+9.9%) | $40.94 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $8.87 M(-14.4%) | $41.91 M(-2.8%) |
| Jun 2021 | - | $10.36 M(-13.3%) | $43.14 M(+1.0%) |
| Mar 2021 | - | $11.95 M(+11.5%) | $42.70 M(+26.0%) |
| Dec 2020 | $33.89 M(+300.6%) | $10.72 M(+6.2%) | $33.89 M(+29.3%) |
| Sep 2020 | - | $10.10 M(+1.7%) | $26.20 M(+46.0%) |
| Jun 2020 | - | $9.92 M(+216.0%) | $17.95 M(+80.0%) |
| Mar 2020 | - | $3.14 M(+3.5%) | $9.97 M(+17.8%) |
| Dec 2019 | $8.46 M(+73.5%) | $3.04 M(+64.6%) | $8.46 M(+56.0%) |
| Sep 2019 | - | $1.84 M(-5.2%) | $5.42 M(+51.5%) |
| Jun 2019 | - | $1.95 M(+19.2%) | $3.58 M(+119.2%) |
| Mar 2019 | - | $1.63 M | $1.63 M |
| Dec 2018 | $4.88 M | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual SGA year-on-year change?
- What is Zentalis Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly SGA year-on-year change?
- What is Zentalis Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM SGA year-on-year change?
What is Zentalis Pharmaceuticals annual SGA?
The current annual SGA of ZNTL is $64.35 M
What is the all time high annual SGA for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual SGA is $64.35 M
What is Zentalis Pharmaceuticals annual SGA year-on-year change?
Over the past year, ZNTL annual SGA has changed by +$9.80 M (+17.96%)
What is Zentalis Pharmaceuticals quarterly SGA?
The current quarterly SGA of ZNTL is $14.61 M
What is the all time high quarterly SGA for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly SGA is $19.64 M
What is Zentalis Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ZNTL quarterly SGA has changed by -$1.34 M (-8.43%)
What is Zentalis Pharmaceuticals TTM SGA?
The current TTM SGA of ZNTL is -$3.74 B
What is the all time high TTM SGA for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM SGA is -$82.99 M
What is Zentalis Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ZNTL TTM SGA has changed by -$3.80 B (-6426.93%)